BGNE Stock Summary and Trading Ideas (Beigene Ltd. - American Depositary Shares | NASDAQ:BGNE)

BeiGene Ltd is a commercial-stage biotechnology company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1. Its geographical segments are China, the United States, and the Rest of the world.

Beigene Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol BGNE.

As of May 9, 2024, BGNE stock price climbed to $168.64 with 244,218 million shares trading.

BGNE has a beta of 1.52, meaning it tends to be more sensitive to market movements. BGNE has a correlation of 0.16 to the broad based SPY ETF.

BGNE has a market cap of $19.13 billion. This is considered a Large Cap stock.

Last quarter Beigene Ltd. - American Depositary Shares reported $752 million in Revenue and -$2.41 earnings per share. This beat revenue expectation by $77 million and exceeded earnings estimates by $.48.

In the last 3 years, BGNE stock traded as high as $426.56 and as low as $118.18.

The top ETF exchange traded funds that BGNE belongs to (by Net Assets): IBB, FBT, BBH, QQQJ, ONEQ.

BGNE stock has underperformed the market in the last year with a return of -31.4%, while SPY returned +28.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BGNE shares. However, BGNE has outperformed the market in the last 3 month and 2 week periods, returning +14.7% and +13.5%, while SPY returned +4.1% and +3.3%, respectively. This indicates BGNE has been having a stronger performance recently.

BGNE support price is $160.26 and resistance is $168.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BGNE stock will trade within this expected range on the day.